High level expression of human basic fibroblast growth factor in Escherichia coli: Evaluating the effect of the GC content and rare codons within the first 13 codons

African Journal of Biotechnology

Volumn 9, Issue 16, 2010, Pages 2456-2462

  Alibolandi, Mona ^a   Mirzahoseini, Hasan ^a   Abad, Mehri Abedi Khalil ^b   Azami movahed, Mehrnaz ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Codon optimization; GC content reduction; Modified gene; Translation initiation region mutagenesis

Indexed keywords

COMPLEMENTARY DNA; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BIOTECHNOLOGICAL PRODUCTION; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA MODIFICATION; EMBRYO; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE CONSTRUCT; GENE EXPRESSION; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN FUNCTION; WILD TYPE;

ESCHERICHIA COLI;

EID: 77951763712     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
2. Brinkmann U, Mattes RE, Buckel P (1989). High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene 85: 109-114.
3. Brocca S, Schmidt-Dannert C, Lotti M, Alberghina L, Schmid RD (1998). Design, total synthesis, and functional overexpression of the Candida rugosa lip1 gene coding for a major industrial lipase. Protein Sci. 7(6): 1415-1422.
4. Bussow K, Scheich C, Sievert V, Harttig U, Schultz J, Simon B, Bork P, Lehrach H, Heinemann U (2005). Structural genomins of human proteins target selection and generation of a public catalogue of expression clones. Microb. Cell Fact. 4: 21.
5. Calderone TL, Stevens RD, Oas TG (1996). High-level misincorporation of lysine for arginine at AGA codons in a fusion protein expressed in Escherichia coli. J. Mol. Biol. 262: 407-412.
6. Casimiro DR, Wright PE, Dyson HJ (1997). PCR-based gene synthesis for protein overproduction. Structure, 5: 1407-1412.
7. Chen GF, Inouye M (1990). Suppression of the negative effect of minor arginine codons on gene expression: preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. Nucleic Acids Res. 18: 1465-1473.
8. Chen GT, Inouye M (1994). Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. Genes Dev. 8(21): 2641-2652.
9. Cormack BP, Bertram G, Egerton M, Gow NA, Falkow S, Brown AJ (1997). Yeast-enhanced green fluorescent protein (yEGFP) a reporter of gene expression in Candida albicans. Microbiol. 143(2): 303-11.
10. De Smit MH, Van Duin J (1990). Secondary structure of the ribosome binding site determines translational efficiency: A quantitative analysis. Proc. Natl. Acad. Sci. USA, 87(19): 7668-7672.
11. Gold L, Pribnow D, Schneider T, Shinedling S, Singer BS, Stormo G (1981). Translational Initiation in Prokaryotes. Ann. Rev. Microbiol. 35: 365-403.
12. Goldman E, Rosenberg AH, Zubay G, Studier FW (1995). Consecutive low-usage leucine codons block translation only when near the 5' end of a message in Escherichia coli. J. Mol. Biol. 245: 467-473.
13. Griswold KE, Mahmood NA, Iverson BL, Georgiou G (2003). Effects of codon usage versus putative 5'-mRNA structure on the expression of Fusarium solani cutinase in the Escherichia coli cytoplasm. Protein Expr. Purif. 27: 134-142.
14. Gustafsson C, Govindarajan S, Minshull J (2004). Codon bias and heterologous protein expression. Trends Biotechnol. 22: 346-353.
15. Hale RS, Thompson G (1998). Codon optimization of the gene encoding a domain from human type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli. Protein Expr. Purif. 12: 185-188.
16. Hamdan FF, Mousa A, Ribeiro P (2002). Codon optimization improves heterologous expression of a Schistosoma mansoni cDNA in HEK293 cells. Parasitol. Res. 88: 583-586.
17. Hanning G, Makrides SC (1998). Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol. 16: 54-60.
18. Ikemura T (1981). Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the E. coli translational system. J. Mol. Biol. 151: 389-409.
19. Ishida M, Oshima T (1994). Over-expression of genes of an extreme thermophile thermos thermophilus, in Escherichia coli cells. J. Bacteriol. 176(9): 2767-2770.
20. Ishida M, Oshima T (2002). Effective Structure of a Leader Open Reading Frame for Enhancing the Expression of GC-Rich Genes. J. Biochem. 132(1): 63-70.
21. Jiang X, Li S, Zhou A, Li F, Xu X, Zhu D (1996). Translation initiation region plays an important role in the expression of human thrombopoietin in Escherichia coli. IUBMB Life 39(6): 1109-1113.
22. Johansson AS, Bolton-Grob R, Mannervik B (1999). Use of silent mutations in cDNA encoding human glutathione transferase M2-2 for optimized expression in Escherichia coli. Protein Expr. Purif. 17(1): 105-12.
23. Kim CH, Oh Y, Lee TH (1997). Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene 199: 293-301.
24. Kleber-Janke T, Becker WM (2000). Use of modified BL21 (DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage. Protein Expr. Purif. 19: 419-424.
25. Kozak M (1999). Initiation of translation in prokaryotes and eukaryotes. Review Gene 234: 187-208.
26. Kurland CG (1991). Codon bias and gene expression. FEBS letters 285(2): 165-9.
27. Laemali UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
28. Li A, Kato Z, Ohnishi H, Hashimoto K, Matsukuma E, Omoya K, Yamamoto Y, Kondo N (2003). Optimized gene synthesis and high expression of human interleukin-18. Protein Expr. Purif. 32: 110-118.
29. Makoff AJ, Oxer MD, Romanos MA, Fairweather NF, Ballantinel S (1989). Expression of tetanus toxin fragnent C in E. coli: high level expression by removing rare codons. Nucleic Acids Res. 17: 10191-10202.
30. Makrides SC (1996). Strategies for Achieving High-Level Expression of Genes in Escherichia coli. Microbiol. Rev. 60: 512-538.
31. Merril CR, Gottesman ME, Adhya SL (1981). Escherichia coli gal operone proteins made after prophage lambda induction. J. Bacteriol. 147(3): 875-87.
32. Mirzabekov T, Bannert N, Farzan M, Hofmann W, Kolchinsky P, Wu L, Wyatt R, Sodroski J (1999). Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 co-receptor. J. Biol. Chem. 274(40): 28745-50.
33. Mirzahoseini H, Mohammadi NS, Arabi M, Arfaee H, Omidinia E (2007). The Effect of Vector with Higher Control System in hbFGF Leaky Expression in Escherichia coli. Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Edited by Antonio Mendez-Vilas. Formatex 1(2): 936-940.
34. Pan W, Ravot E, Tolle R, Frank R, Mosbach R, Turbachova I, Bujard H (1999). Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. Nucleic Acids Res. 27: 1094-1103.
35. Prapunwattana P, Sirawaraporn W, Yuthavong Y, Santi DV (1996). Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Mol. Biochem. Parasitol. 83: 93-106.
36. Queen C, Rosenberg M (1981). Differential translation efficiency explains discoordinate expression of the galactose operon. Cell 25(1): 241-249.
37. Rangwala SH, Finn RF, Smith CE, Berberich SA, Salsgiver WJ, Stallings WC, Glover GL, Olins PO (2003). High-level production of active HIV-I protease in Escherichia coli. J. Neurosci. Methods 124(1): 75-81.
38. Rosenberg AH, Goldman E, Dunn JJ, Studier FW, Zubay G (1993). Effects of consecutive AGG codons on translation in Escherichia coli, demonstrated with a versatile codon test system. J. Bacteriol. 175(3): 716-722.
39. Sahdev S, Khattar SK, Saini KS (2008). Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies. Mol. Cell Biochem. 307: 249-264.
40. Sorensen HP, Mortensen KK (2005). Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115: 113-128.
41. Sprengart ML, Fatscher HP, Fuchs F (1990). The initiation of translation in E. coli: apparent base pairing between the 16srRNA and downstream sequences of the mRNA. Nucleic Acids Res. 18(7): 1719-1723.
42. Terpe K (2006). Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 72: 211-222.
43. Uchijima M, Yoshida A, Nagata T, Koide Y (1998). Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161(10): 5594-9.
44. Wu X, Jornvall H, Berndt KD, Oppermann U (2004). Codon optimization reveals critical factors for high level expression of two rare codon genes in Escherichia coli: RNA stability and secondary structure but not tRNA abundance. Biochem. Biophys. Res. Commun. 313: 89-96.
45. Zahn K (1996). Over-expression of an mRNA dependent on rare codons inhibits protein synthesis and cell growth. J. Bacteriol. 178: 2926-2933.
46. Zhang MY, Schillberg S, Prins M, Fischer R (1999). Optimizing expression of a rare codon-rich viral protein in Escherichia coli using the IMPACT system. Anal. Biochem. 271: 202-204.